Bo Chen
Central South University of Forestry and Technology(CN)Tianjin University of Traditional Chinese Medicine(CN)Fujian Medical University(CN)Central South University(CN)Jinan University(CN)Kunming Medical University(CN)Second Affiliated Hospital of Guangzhou Medical University(CN)Neijiang Normal University(CN)Shanghai East Hospital(CN)Henan Cancer Hospital(CN)Guangdong Academy of Medical Sciences(CN)Guangdong Provincial People's Hospital(CN)Union Hospital(CN)Gaozhou People's Hospital(CN)Southern Medical University(CN)University of California, Davis(US)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, RNA modifications and cancer, Ferroptosis and cancer prognosis, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Detection of COVID-19: A review of the current literature and future perspectives(2020)391 cited
- → The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation(2007)186 cited
- → MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis(2015)144 cited
- → Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status(2022)135 cited
- → S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo(2015)125 cited
- → Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer(2019)104 cited